| CVX | CVX Label | Use Status | Comment |
|---|---|---|---|
| 801 | AS03 Adjuvant | SUPPORTED | Problem: No forecast series references this code |
| 143 | Adenovirus types 4 and 7 | SUPPORTED | Problem: No forecast series references this code |
| 19 | BCG | SUPPORTED | Problem: No forecast series references this code |
| 29 | CMVIG | SUPPORTED | Problem: No forecast series references this code |
| 207 | COVID-19, mRNA, LNP-S, PF, 100 mcg/0.5 mL dose | SUPPORTED | |
| 208 | COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose | SUPPORTED | |
| 28 | DT (pediatric) | SUPPORTED | |
| 195 | DT, IPV adsorbed | SUPPORTED | Problem: No forecast series references this code |
| 170 | DTAP/IPV/HIB - non-US | SUPPORTED | |
| 01 | DTP | SUPPORTED | |
| 22 | DTP-Hib | SUPPORTED | |
| 102 | DTP-Hib-Hep B | SUPPORTED | |
| 198 | DTP-hepB-Hib Pentavalent Non-US | SUPPORTED | |
| 20 | DTaP | SUPPORTED | |
| 106 | DTaP, 5 pertussis antigens | SUPPORTED | |
| 107 | DTaP, unspecified formulation | SUPPORTED | |
| 146 | DTaP,IPV,Hib,HepB | SUPPORTED | |
| 110 | DTaP-Hep B-IPV | SUPPORTED | |
| 50 | DTaP-Hib | SUPPORTED | |
| 120 | DTaP-Hib-IPV | SUPPORTED | |
| 130 | DTaP-IPV | SUPPORTED | |
| 132 | DTaP-IPV-HIB-HEP B, historical | SUPPORTED | |
| 30 | HBIG | SUPPORTED | Problem: No forecast series references this code |
| 61 | HIV | SUPPORTED | Problem: No forecast series references this code |
| 118 | HPV, bivalent | SUPPORTED | |
| 62 | HPV, quadrivalent | SUPPORTED | |
| 137 | HPV, unspecified formulation | SUPPORTED | Problem: No forecast series references this code |
| 165 | HPV9 | SUPPORTED | |
| 52 | Hep A, adult | SUPPORTED | |
| 169 | Hep A, live attenuated | SUPPORTED | Problem: No forecast series references this code |
| 83 | Hep A, ped/adol, 2 dose | SUPPORTED | |
| 84 | Hep A, ped/adol, 3 dose | SUPPORTED | |
| 31 | Hep A, pediatric, unspecified formulation | SUPPORTED | |
| 85 | Hep A, unspecified formulation | SUPPORTED | |
| 104 | Hep A-Hep B | SUPPORTED | |
| 193 | Hep A-Hep B, pediatric/adolescent | SUPPORTED | Problem: No forecast series references this code |
| 08 | Hep B, adolescent or pediatric | SUPPORTED | |
| 42 | Hep B, adolescent/high risk infant | SUPPORTED | |
| 43 | Hep B, adult | SUPPORTED | |
| 44 | Hep B, dialysis | SUPPORTED | |
| 45 | Hep B, unspecified formulation | SUPPORTED | |
| 58 | Hep C | SUPPORTED | Problem: No forecast series references this code |
| 59 | Hep E | SUPPORTED | Problem: No forecast series references this code |
| 189 | HepB-CpG | SUPPORTED | Problem: No forecast series references this code |
| 154 | Hepatitis A immune globulin | SUPPORTED | Problem: No forecast series references this code |
| 47 | Hib (HbOC) | SUPPORTED | |
| 46 | Hib (PRP-D) | SUPPORTED | |
| 49 | Hib (PRP-OMP) | SUPPORTED | |
| 48 | Hib (PRP-T) | SUPPORTED | |
| 17 | Hib, unspecified formulation | SUPPORTED | |
| 51 | Hib-Hep B | SUPPORTED | |
| 86 | IG | SUPPORTED | Problem: No forecast series references this code |
| 14 | IG, unspecified formulation | SUPPORTED | Problem: No forecast series references this code |
| 87 | IGIV | SUPPORTED | Problem: No forecast series references this code |
| 10 | IPV | SUPPORTED | |
| 160 | Influenza A monovalent (H5N1), ADJUVANTED-2013 | SUPPORTED | Problem: No forecast series references this code |
| 151 | Influenza nasal, unspecified formulation | SUPPORTED | |
| 205 | Influenza vaccine, quadrivalent, adjuvanted | SUPPORTED | Problem: No forecast series references this code |
| 194 | Influenza, Southern Hemisphere | SUPPORTED | Problem: No forecast series references this code |
| 135 | Influenza, high dose seasonal | SUPPORTED | |
| 153 | Influenza, injectable, MDCK, preservative free | SUPPORTED | |
| 171 | Influenza, injectable, MDCK, preservative free, quadrivalent | SUPPORTED | |
| 186 | Influenza, injectable, MDCK, quadrivalent | SUPPORTED | |
| 158 | Influenza, injectable, quadrivalent | SUPPORTED | |
| 150 | Influenza, injectable, quadrivalent, preservative free | SUPPORTED | Problem: No forecast series references this code |
| 161 | Influenza, injectable,quadrivalent, preservative free, pediatric | SUPPORTED | |
| 111 | Influenza, live, intranasal | SUPPORTED | |
| 155 | Influenza, recombinant, injectable, preservative free | SUPPORTED | |
| 141 | Influenza, seasonal, injectable | SUPPORTED | |
| 140 | Influenza, seasonal, injectable, preservative free | SUPPORTED | |
| 144 | Influenza, seasonal, intradermal, preservative free | SUPPORTED | |
| 15 | Influenza, split (incl. purified surface antigen) | SUPPORTED | |
| 88 | Influenza, unspecified formulation | SUPPORTED | |
| 16 | Influenza, whole | SUPPORTED | Problem: No forecast series references this code |
| 134 | Japanese Encephalitis IM | SUPPORTED | Problem: No forecast series references this code |
| 129 | Japanese Encephalitis, unspecified formulation | SUPPORTED | Problem: No forecast series references this code |
| 39 | Japanese encephalitis SC | SUPPORTED | Problem: No forecast series references this code |
| 63 | Junin virus | SUPPORTED | Problem: No forecast series references this code |
| 66 | Lyme disease | SUPPORTED | Problem: No forecast series references this code |
| 03 | MMR | SUPPORTED | |
| 94 | MMRV | SUPPORTED | |
| 04 | Measles and Rubella | SUPPORTED | |
| 148 | Meningococcal C/Y-HIB PRP | SUPPORTED | |
| 136 | Meningococcal MCV4O | SUPPORTED | |
| 128 | Novel Influenza-H1N1-09, all formulations | SUPPORTED | |
| 125 | Novel Influenza-H1N1-09, nasal | SUPPORTED | |
| 127 | Novel influenza-H1N1-09 | SUPPORTED | |
| 126 | Novel influenza-H1N1-09, preservative-free | SUPPORTED | |
| 02 | OPV | SUPPORTED | |
| 179 | OPV ,monovalent, unspecified | SUPPORTED | Problem: No forecast series references this code |
| 178 | OPV bivalent | SUPPORTED | Problem: No forecast series references this code |
| 182 | OPV, Unspecified | SUPPORTED | Problem: No forecast series references this code |
| 177 | PCV10 | SUPPORTED | Problem: No forecast series references this code |
| 152 | Pneumococcal Conjugate, unspecified formulation | SUPPORTED | Problem: No forecast series references this code |
| 133 | Pneumococcal conjugate PCV 13 | SUPPORTED | |
| 70 | Q fever | SUPPORTED | Problem: No forecast series references this code |
| 99 | RESERVED - do not use | SUPPORTED | Problem: No forecast series references this code |
| 34 | RIG | SUPPORTED | Problem: No forecast series references this code |
| 71 | RSV-IGIV | SUPPORTED | Problem: No forecast series references this code |
| 93 | RSV-MAb | SUPPORTED | Problem: No forecast series references this code |
| 145 | RSV-Mab (new) | SUPPORTED | Problem: No forecast series references this code |
| 175 | Rabies - IM Diploid cell culture | SUPPORTED | Problem: No forecast series references this code |
| 176 | Rabies - IM fibroblast culture | SUPPORTED | Problem: No forecast series references this code |
| 157 | Rho(D) -IG IM | SUPPORTED | Problem: No forecast series references this code |
| 159 | Rho(D) Unspecified formulation | SUPPORTED | Problem: No forecast series references this code |
| 156 | Rho(D)-IG | SUPPORTED | Problem: No forecast series references this code |
| 73 | Rift Valley fever | SUPPORTED | Problem: No forecast series references this code |
| 213 | SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED | SUPPORTED | |
| 206 | Smallpox monkeypox vaccine (National Stockpile) | SUPPORTED | Problem: No forecast series references this code |
| 76 | Staphylococcus bacterio lysate | SUPPORTED | Problem: No forecast series references this code |
| 13 | TIG | SUPPORTED | Problem: No forecast series references this code |
| 98 | TST, unspecified formulation | SUPPORTED | Problem: No forecast series references this code |
| 95 | TST-OT tine test | SUPPORTED | Problem: No forecast series references this code |
| 96 | TST-PPD intradermal | SUPPORTED | Problem: No forecast series references this code |
| 97 | TST-PPD tine test | SUPPORTED | Problem: No forecast series references this code |
| 138 | Td (adult) | SUPPORTED | Problem: No forecast series references this code |
| 113 | Td (adult) preservative free | SUPPORTED | |
| 09 | Td (adult), adsorbed | SUPPORTED | |
| 139 | Td(adult) unspecified formulation | SUPPORTED | Problem: No forecast series references this code |
| 196 | Td, adsorbed, preservative free, adult use, Lf unspecified | SUPPORTED | Problem: No forecast series references this code |
| 115 | Tdap | SUPPORTED | |
| 190 | Typhoid conjugate vaccine (TCV) | SUPPORTED | Problem: No forecast series references this code |
| 81 | VEE, inactivated | SUPPORTED | Problem: No forecast series references this code |
| 80 | VEE, live | SUPPORTED | |
| 92 | VEE, unspecified formulation | SUPPORTED | Problem: No forecast series references this code |
| 36 | VZIG | SUPPORTED | Problem: No forecast series references this code |
| 117 | VZIG (IND) | SUPPORTED | Problem: No forecast series references this code |
| 183 | Yellow fever vaccine - alt | SUPPORTED | Problem: No forecast series references this code |
| 184 | Yellow fever, unspecified formulation | SUPPORTED | Problem: No forecast series references this code |
| 54 | adenovirus, type 4 | SUPPORTED | Problem: No forecast series references this code |
| 55 | adenovirus, type 7 | SUPPORTED | Problem: No forecast series references this code |
| 82 | adenovirus, unspecified formulation | SUPPORTED | Problem: No forecast series references this code |
| 24 | anthrax | SUPPORTED | Problem: No forecast series references this code |
| 181 | anthrax immune globulin | SUPPORTED | Problem: No forecast series references this code |
| 27 | botulinum antitoxin | SUPPORTED | Problem: No forecast series references this code |
| 26 | cholera | SUPPORTED | Problem: No forecast series references this code |
| 173 | cholera, BivWC | SUPPORTED | Problem: No forecast series references this code |
| 172 | cholera, WC-rBS | SUPPORTED | Problem: No forecast series references this code |
| 174 | cholera, live attenuated | SUPPORTED | Problem: No forecast series references this code |
| 56 | dengue fever | SUPPORTED | Problem: No forecast series references this code |
| 12 | diphtheria antitoxin | SUPPORTED | Problem: No forecast series references this code |
| 57 | hantavirus | SUPPORTED | Problem: No forecast series references this code |
| 60 | herpes simplex 2 | SUPPORTED | Problem: No forecast series references this code |
| 123 | influenza, H5N1-1203 | SUPPORTED | Problem: No forecast series references this code |
| 200 | influenza, Southern Hemisphere, pediatric, preservative free | SUPPORTED | Problem: No forecast series references this code |
| 201 | influenza, Southern Hemisphere, preservative free | SUPPORTED | Problem: No forecast series references this code |
| 202 | influenza, Southern Hemisphere, quadrivalent, with preservative | SUPPORTED | Problem: No forecast series references this code |
| 197 | influenza, high-dose, quadrivalent | SUPPORTED | Problem: No forecast series references this code |
| 166 | influenza, intradermal, quadrivalent, preservative free | SUPPORTED | |
| 149 | influenza, live, intranasal, quadrivalent | SUPPORTED | |
| 185 | influenza, recombinant, quadrivalent,injectable, preservative free | SUPPORTED | |
| 168 | influenza, trivalent, adjuvanted | SUPPORTED | |
| 64 | leishmaniasis | SUPPORTED | Problem: No forecast series references this code |
| 65 | leprosy | SUPPORTED | Problem: No forecast series references this code |
| 67 | malaria | SUPPORTED | Problem: No forecast series references this code |
| 05 | measles | SUPPORTED | |
| 68 | melanoma | SUPPORTED | Problem: No forecast series references this code |
| 191 | meningococcal A polysaccharide (non-US) | SUPPORTED | Problem: No forecast series references this code |
| 192 | meningococcal AC polysaccharide (non-US) | SUPPORTED | Problem: No forecast series references this code |
| 163 | meningococcal B, OMV | SUPPORTED | |
| 162 | meningococcal B, recombinant | SUPPORTED | |
| 164 | meningococcal B, unspecified | SUPPORTED | |
| 103 | meningococcal C conjugate | SUPPORTED | Problem: No forecast series references this code |
| 147 | meningococcal MCV4, unspecified formulation | SUPPORTED | |
| 114 | meningococcal MCV4P | SUPPORTED | |
| 32 | meningococcal MPSV4 | SUPPORTED | |
| 203 | meningococcal polysaccharide (groups A, C, Y, W-135) TT conjugate | SUPPORTED | Problem: No forecast series references this code |
| 167 | meningococcal, unknown serogroups | SUPPORTED | Problem: No forecast series references this code |
| 108 | meningococcal, unspecified formulation | SUPPORTED | |
| 07 | mumps | SUPPORTED | |
| 998 | no vaccine administered | SUPPORTED | Problem: No forecast series references this code |
| 69 | parainfluenza-3 | SUPPORTED | Problem: No forecast series references this code |
| 11 | pertussis | SUPPORTED | Problem: No forecast series references this code |
| 23 | plague | SUPPORTED | Problem: No forecast series references this code |
| 100 | pneumococcal conjugate PCV 7 | SUPPORTED | |
| 33 | pneumococcal polysaccharide PPV23 | SUPPORTED | |
| 109 | pneumococcal, unspecified formulation | SUPPORTED | |
| 89 | polio, unspecified formulation | SUPPORTED | |
| 40 | rabies, intradermal injection | SUPPORTED | Problem: No forecast series references this code |
| 18 | rabies, intramuscular injection | SUPPORTED | |
| 90 | rabies, unspecified formulation | SUPPORTED | Problem: No forecast series references this code |
| 72 | rheumatic fever | SUPPORTED | Problem: No forecast series references this code |
| 119 | rotavirus, monovalent | SUPPORTED | |
| 116 | rotavirus, pentavalent | SUPPORTED | |
| 74 | rotavirus, tetravalent | SUPPORTED | |
| 122 | rotavirus, unspecified formulation | SUPPORTED | |
| 06 | rubella | SUPPORTED | |
| 38 | rubella/mumps | SUPPORTED | |
| 180 | tetanus immune globulin | SUPPORTED | Problem: No forecast series references this code |
| 35 | tetanus toxoid, adsorbed | SUPPORTED | Problem: No forecast series references this code |
| 142 | tetanus toxoid, not adsorbed | SUPPORTED | Problem: No forecast series references this code |
| 112 | tetanus toxoid, unspecified formulation | SUPPORTED | Problem: No forecast series references this code |
| 77 | tick-borne encephalitis | SUPPORTED | Problem: No forecast series references this code |
| 78 | tularemia vaccine | SUPPORTED | Problem: No forecast series references this code |
| 101 | typhoid, ViCPs | SUPPORTED | Problem: No forecast series references this code |
| 25 | typhoid, oral | SUPPORTED | Problem: No forecast series references this code |
| 41 | typhoid, parenteral | SUPPORTED | Problem: No forecast series references this code |
| 53 | typhoid, parenteral, AKD (U.S. military) | SUPPORTED | Problem: No forecast series references this code |
| 91 | typhoid, unspecified formulation | SUPPORTED | Problem: No forecast series references this code |
| 131 | typhus, historical | SUPPORTED | Problem: No forecast series references this code |
| 999 | unknown | SUPPORTED | Problem: No forecast series references this code |
| 75 | vaccinia (smallpox) | SUPPORTED | Problem: No forecast series references this code |
| 105 | vaccinia (smallpox) diluted | SUPPORTED | Problem: No forecast series references this code |
| 79 | vaccinia immune globulin | SUPPORTED | Problem: No forecast series references this code |
| 21 | varicella | SUPPORTED | |
| 37 | yellow fever | SUPPORTED | |
| 121 | zoster | SUPPORTED | |
| 187 | zoster recombinant | SUPPORTED | |
| 188 | zoster, unspecified formulation | SUPPORTED | Problem: No forecast series references this code |